Influenza: Diagnosis, Treatment, Prevention - V.D. Moskaliuk 2010
General information about influenza and other ARVIs
General information about influenza and other ARVI
Etiological heterogeneity of acute respiratory diseases
The role of decreased immunological reactivity of the body in the development of ARVI
Modern concepts of cytokine status in ARVI
Discovery of Influenza Pathogens
Variability and Evolution of Influenza Viruses
Differentiation of Influenza Viruses
Therapeutic Management of ARVI
Therapeutic Measures for ARVI
Therapeutic Management of ARVI
Therapeutic management of ARVI
Therapeutic interventions for ARVI
Microwave resonance therapy (MRT)
Characteristics of patients with influenza A, influenza B, adenoviral and respiratory syncytial infections, and ARVI of undetermined etiology
Clinical characteristics of the examined patients
Characteristics of patients with influenza A, influenza B, adenoviral and respiratory syncytial infections, and ARVI of unknown etiology
Dynamics of clinical signs under the influence of aerosol interferon therapy
Dynamics of cellular immunity parameters under the influence of various treatment methods
Characteristics of patients with influenza A, influenza B, adenoviral and respiratory syncytial infections, and ARVI of undetermined etiology
Dynamics of cardiovascular system changes under the influence of aerosol interferon therapy
Characteristics of patients with influenza A, influenza B, adenoviral and respiratory syncytial infections, as well as ARVI of undetermined etiology
Efficacy of aerosol interferon therapy in combination with Proteflazid
Characteristics of patients with influenza A, influenza B, adenoviral infection, respiratory syncytial infection, and ARVI of unspecified etiology
Efficacy of aerosol interferon therapy combined with microwave resonance therapy